Cédric Dananché
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 7
- Endocrinology top 10%
-
- Nosocomial Infections in ICU 3
-
- Antifungal resistance and susceptibility 6
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
-
- Indoor Air Quality and Microbial Exposure 4
-
- Pneumonia and Respiratory Infections 3
- Influenza Virus Research Studies 2
Cédric Dananché
21 papers receiving 243 citations
Peers
Comparison fields: 5 of 66
- Molecular Medicine 52
- Endocrinology 49
- Critical Care and Intensive Care Medicine 35
- Infectious Diseases 106
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by Cédric Dananché
This map shows the geographic impact of Cédric Dananché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Dananché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Dananché more than expected).
Fields of papers citing papers by Cédric Dananché
This network shows the impact of papers produced by Cédric Dananché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Dananché. The network helps show where Cédric Dananché may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cédric Dananché, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 11 | |
| 11 | 2018 | 8 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 40 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 4 | |
| 17 | 2017 | 1 | |
| 18 | 2017 | 13 | |
| 19 | 2015 | 8 | |
| 20 | 2014 | 12 |
About Cédric Dananché
Cédric Dananché is a scholar working on Molecular Medicine, Infectious Diseases, Endocrinology, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 27 papers that have together received 249 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antifungal resistance and susceptibility (6 papers), COVID-19 Clinical Research Studies (6 papers), Indoor Air Quality and Microbial Exposure (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumonia and Respiratory Infections (3 papers), Nosocomial Infections in ICU (3 papers) and Influenza Virus Research Studies (2 papers). The work is most often cited by research in Molecular Medicine (52 citations), Endocrinology (49 citations), Critical Care and Intensive Care Medicine (35 citations), Infectious Diseases (106 citations) and Applied Microbiology and Biotechnology (11 citations). Cédric Dananché has collaborated with scholars based in France, Mali and Paraguay. Frequent co-authors include Philippe Vanhems, Thomas Bénet, Pierre Cassier, Olivier Dauwalder, Christelle Elias, Marie‐Paule Gustin, Mitra Saadatian‐Elahi, Sophie Loeffert, Xavier Bertrand and Sélilah Amour. Their work appears in journals such as PLoS ONE, American Journal of Infection Control, BMJ Open, Emerging infectious diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.